ANI Pharma (ANIP) Reports Q4 EPS of 84c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to ANI Pharma (ANIP) Reports Q4 EPS of 84c

ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance

March 2, 2017 8:30 AM EST

BAUDETTE, Minn., March 2, 2017 /PRNewswire/ --

For the full year ended December 31, 2016:

Record net revenues of $128.6 million, an increase of 69% versus the prior year GAAP net income of $3.9 million, including $6.7 million non-cash impairment charge for a non-core asset Diluted GAAP earnings per share of $0.34, including impact of non-cash impairment charge of $0.36, net of tax Adjusted non-GAAP EBITDA of $61.1 million Adjusted non-GAAP net income per diluted share of $3.78 (previous methodology)

For the fourth quarter 2016:

Net... More